European Companies Search Engine

13 EU fundings (€529,687): European Screening Centre; Unique Library for Attractive Biology … Bdl Year 2018 EU Research and Innovation programme "Horizon"

Text

District Court of Cologne HRB 48248

01/06/2018 EU funding (€1,750,000): The GetReal Initiative
01/04/2018 EU funding (€11.2M): Improving the care of patients suffering from acute or chronic pain
01/07/2018 EU funding (€12M): Research empowerment on solute carriers (ReSOLUTE)
01/11/2018 EU funding (€14.1M): European Health Data and Evidence Network
01/12/2018 EU funding (€18.2M): European Screening Centre; Unique Library for Attractive Biology
12/11/2018 EU funding (€3,792,136): A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies
28/06/2018 EU funding (€3,923,653): Quantitative T cell Immunology and Immunotherapy
01/09/2018 EU funding (€365,243): Ensuring the future of EUPATI beyond 2020
01/03/2018 EU funding (€4,498,931): Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.
01/05/2018 EU funding (€4,700,000): Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production
01/05/2018 EU funding (€4,999,999): RustWatch: A European early-warning system for wheat rust diseases
01/05/2018 EU funding (€5,962,801): Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope
01/05/2018 EU funding (€67M): conect4children (COllaborative Network for European Clinical Trials For Children)

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Bayer AG, Leverkusen, Germany.